![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](zl2063contents.gif)
Acta Cryst. (2007). E63, m2574 [ doi:10.1107/S1600536807044716 ]
N)(
5-pentamethylcyclopentadienyl)(pyrimidine-
N)rhodium(III) bis(hexafluoridophosphate)Abstract: The title compound, [Rh(C10H15)(C4H4N2)(C2H3N)2](PF6)2 or [Cp*Rh(NCMe)2(N2C4H4)](PF6)2, where Cp* is pentamethylcyclopentadienyl, was obtained from the treatment of an acetonitrile solution of [Cp*Rh(NCMe)3](PF6)2 with an excess of pyrimidine. The RhIII center is coordinated by one Cp* ring, two acetonitrile ligands and one pyrimidine ligand in a pseudo-octahedral geometry. Both PF6 anions are disordered (site occupancies ca 0.4:0.6, and 0.3:0.4:0.3).
Online 21 September 2007
Copyright © International Union of Crystallography
IUCr Webmaster